Geoffrey Oxnard, Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Geoffrey Oxnard, Dana-Farber Cancer Institute

Caption

Dr. Geoffrey Oxnard helped lead a study showing non-small cell lung cancer (NSCLC) in younger patients is a distinct disease, genetically and biologically, from NSCLC in older patients and may require a different treatment approach.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.